Palouse Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Devon Energy
DVN
|
+$4.04M |
| 2 |
Pfizer
PFE
|
+$3.68M |
| 3 |
Lockheed Martin
LMT
|
+$3.13M |
| 4 |
Costco
COST
|
+$3.02M |
| 5 |
Merck
MRK
|
+$2.84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$3.7M |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$2.88M |
| 3 |
Amdocs
DOX
|
+$2.55M |
| 4 |
Applied Materials
AMAT
|
+$2.41M |
| 5 |
Ulta Beauty
ULTA
|
+$1.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.43% |
| 2 | Technology | 14.97% |
| 3 | Financials | 12.89% |
| 4 | Consumer Staples | 9.56% |
| 5 | Industrials | 8.78% |
Similar funds
Palouse Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Palouse Capital Management held 101 positions worth $227M, up 20% from $189M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Palouse Capital Management deployed $15.8M of net new capital in Q1 2021, opening 14 new positions and adding to 27 existing holdings. Its largest new stake was Devon Energy: 196,200 shares worth $4.29M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 21% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Huntington Bancshares, an estimated $216K trimmed.
- Palouse Capital Management's largest Q1 2021 buy was Devon Energy: 196,200 shares worth $4.29M.
- Palouse Capital Management added most to Lockheed Martin in Q1 2021, an estimated $3.13M increase.
- Palouse Capital Management's biggest Q1 2021 reduction was Huntington Bancshares, cutting an estimated $216K.
- Palouse Capital Management fully exited Walgreens Boots Alliance in Q1 2021, selling an estimated $3.7M.
- Palouse Capital Management's ten largest holdings make up 27% of its $227M portfolio in Q1 2021.
- Palouse Capital Management opened 14 new positions and closed 7 in Q1 2021.
- Palouse Capital Management's portfolio value rose 20% quarter-over-quarter to $227M.
Based on Palouse Capital Management's 13F filing for Q1 2021, filed 11 May 2021.